US proposes restricting weight-loss drug copies
The US Food and Drug Administration (FDA) has proposed new restrictions that would limit the ability of outsourcing facilities to produce compounded versions of popular weight-loss and diabetes medications. In a statement on Thursday, April 30, the agency said it plans to exclude certain active ingredients used in these drugs from the bulk substances list…